Price Alert

Skye Bioscience Inc. (SKYE)

NASDAQ: SKYE · Real-Time Price · USD

3.53

0.26 (7.95%)

At close: Aug 15, 2025, 3:59 PM

3.51

-0.57%

After-hours: Aug 15, 2025, 07:36 PM EDT

Skye Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	23.84M	46.42M	68.42M	67.41M	74.12M	83.34M	1.26M	5.13M	553.44K	2.67M	1.24M	415.39K	2.93M	6.01M	8.98M	11.09M	5.19M	5.15M
Short-Term Investments	24.75M	12.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	53.91K	53.91K	53.91K	26.31K	8.31K	8.31K	8.31K	8.31K	8.31K	8.31K	8.31K	8.31K	8.31K	8.31K	8.31K	8.31K	4K	n/a
Receivables	13.48K	6.39K	5.07K	3.68K	20.00	149.28K	158.24K	850.61K	747.46K	487.53K	74.12K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	-755.94K	-1.06M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.98M	160.37K	207.21K	12.39M	9.63M	9.62M	10.39M	10.16M	38.34K	54.33K	6.74M	1.56M	972.61K	114.32K	61.44K	4.57K	4.57K	4.57K
Total Current Assets	50.58M	63.03M	70.83M	79.81M	87M	94.57M	11.65M	15.29M	1.89M	4.45M	8.94M	2.68M	4.77M	6.99M	9.61M	11.43M	5.47M	5.38M
Property-Plant & Equipment	1.52M	1.71M	1.88M	1.7M	248.76K	256.88K	281.26K	309.83K	334.95K	127.73K	159.04K	177.23K	185.23K	209.7K	234.68K	244.97K	15.56K	17.1K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.58M	1.77M	1.94M	1.73M	257.07K	265.19K	289.57K	318.14K	343.26K	136.04K	167.35K	185.54K	193.54K	218.01K	242.99K	253.28K	19.56K	17.1K
Total Assets	52.16M	64.79M	72.76M	81.54M	87.26M	94.84M	11.94M	15.6M	2.24M	4.59M	9.11M	2.87M	4.97M	7.21M	9.86M	11.69M	5.49M	5.4M
Account Payables	3.22M	1.71M	569.25K	780.02K	1.08M	1.1M	1.16M	1.64M	1.66M	1.33M	1.79M	2.19M	1.55M	902.75K	900.01K	338.98K	397.18K	509.85K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	195.05K	n/a	n/a	82.93K	4.86M	4.61M	4.37M	4.17M	90.61K	158.58K	1.9M	2.49M	2.41M	2.34M	1.97M	n/a	n/a	103.52K
Other Current Liabilities	4.03M	796.73K	549.15K	4.68M	7.23M	7.05M	7.03M	6.5M	6.43M	6.34M	7.48M	629.53K	573.48K	394.18K	435.57K	705.31K	951.7K	595.78K
Total Current Liabilities	8.31M	5.32M	4.34M	5.62M	14.32M	15.8M	13.9M	13.72M	9.82M	9.37M	12.12M	6.15M	5.24M	4.18M	3.91M	1.5M	1.55M	1.38M
Long-Term Debt	172.49K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.82M	1.67M	1.54M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	172.49K	223.47K	273.16K	108.06K	129.91K	150.95K	171.23K	190.51K	208.59K	n/a	n/a	8.23K	32.42K	55.91K	78.7K	1.92M	1.67M	1.54M
Total Liabilities	8.48M	5.54M	4.61M	5.73M	14.45M	15.95M	14.07M	13.91M	10.03M	9.37M	12.12M	6.15M	5.27M	4.24M	3.99M	3.42M	3.22M	2.92M
Total Debt	367.54K	412.11K	455.59K	190.99K	5.07M	4.84M	4.62M	4.43M	364.65K	239.89K	1.98M	2.59M	2.53M	2.49M	2.14M	1.98M	1.67M	1.64M
Common Stock	30.99K	30.98K	30.98K	30.34K	28.07K	28.06K	12.35K	12.34K	971.55K	971.55K	3.65K	495.93K	495.93K	495.93K	476.11K	476.11K	396.08K	367.64K
Retained Earnings	-159.68M	-142.05M	-130.95M	-121.2M	-117.3M	-109.4M	-104.38M	-99.96M	-75.02M	-71.91M	-66.74M	-56.85M	-53.72M	-50.3M	-47.26M	-44.74M	-42.92M	-40.89M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	43.68M	59.25M	68.15M	75.8M	72.81M	78.88M	-2.13M	1.7M	-7.79M	-4.78M	-3.01M	-3.28M	-301.82K	2.97M	5.86M	8.26M	2.27M	2.48M
Total Investments	24.75M	12.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a